Clinical Trials in Hammond, Louisiana
17 recruiting
Showing 1–17 of 17 trials
Recruiting
Not Applicable
Evaluating the Efficacy of NeoThelium FT in the Treatment of Chronic Open Wounds
Open Wound
NuScience Medical Biologics, LLC132 enrolled14 locationsNCT06918561
Recruiting
Not Applicable
Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers
Diabetic Foot Ulcer
NuScience Medical Biologics, LLC132 enrolled8 locationsNCT06938685
Recruiting
Phase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
ObesityHeart Failure With Preserved Ejection FractionHeart Failure With Mildly Reduced Ejection Fraction
Amgen5,056 enrolled603 locationsNCT07037459
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
Stryker Instruments8,000 enrolled2262 locationsNCT03072927
Recruiting
Phase 3
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart FailureAcute Heart Failure
Colorado Prevention Center5,200 enrolled299 locationsNCT06008197
Recruiting
Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Boehringer Ingelheim4,200 enrolled638 locationsNCT06935370
Recruiting
Phase 3
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Boehringer Ingelheim6,000 enrolled653 locationsNCT06424288
Recruiting
Phase 3
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
AstraZeneca15,100 enrolled1264 locationsNCT07000357
Recruiting
Phase 3
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
HypertensionHigh Risk Cardiovascular DiseaseHigh Cardiovascular Risk
Alnylam Pharmaceuticals11,000 enrolled597 locationsNCT07181109
Recruiting
Not Applicable
Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Open Wounds
Open Wound
NuScience Medical Biologics, LLC10 enrolled1 locationNCT07041177
Recruiting
Phase 3
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Patients With Non-small-cell Lung Cancer
OSE Immunotherapeutics363 enrolled207 locationsNCT06472245
Recruiting
Shield Post-Approval Study Protocol
Colo-rectal Cancer
Guardant Health, Inc.3,375 enrolled56 locationsNCT06880055
Recruiting
Phase 3
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
Heart Failure
Novo Nordisk A/S5,600 enrolled1117 locationsNCT05636176
Recruiting
Prospective Study to Assess a Diagnostic Aid for Cancer
Cancer
Harbinger Health1,650 enrolled39 locationsNCT07046260
Recruiting
Phase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
DalCor Pharmaceuticals2,000 enrolled223 locationsNCT05918861
Recruiting
AngelMed Guardian® System PMA Post Approval Study
Acute Coronary Syndrome
Angel Medical Systems500 enrolled18 locationsNCT05412927
Recruiting
Not Applicable
Amnio-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
Diabetic Foot Ulcer
Capsicure, LLC150 enrolled12 locationsNCT06572839